Know Cancer

or
forgot password

    • cancer clinical trials in durham, NC

    • Allogeneic Mixed Chimerism Stem Cell Transplant Using Campath for Hemoglobinopathies & Bone Marrow Failure Syndromes
    Duke Cancer Institute
    Durham, North Carolina 27710
    Sickle Cell Anemia, Severe Aplastic Anemia, Paroxysmal Nocturnal Hemoglobinuria (PNH), Pure Red Cell Aplasia
    Capecitabine in Treating Patients With Malignant Mesothelioma
    Duke Comprehensive Cancer Center

    Trial Locations
    Duke Comprehensive Cancer Center
    Veterans Affairs Medical Center - Durham
    Malignant Mesothelioma
    Biological Therapy in Treating Patients With Metastatic Cancer
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Breast Cancer, Colorectal Cancer, Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Gastric Cancer, Head and Neck Cancer, Liver Cancer, Lung Cancer, Metastatic Cancer, Ovarian Cancer, Pancreatic Cancer, Testicular Germ Cell Tumor
    Positron Emission Tomography in Determining Stage of Esophageal Cancer
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Esophageal Cancer
    Interleukin-12 in Treating Patients With Metastatic or Recurrent Breast Cancer
    Duke Comprehensive Cancer Center

    Trial Locations
    Duke Comprehensive Cancer Center
    Veterans Affairs Medical Center - Durham
    Breast Cancer
    Etanercept for Wegener's Granulomatosis
    Duke University
    Durham, North Carolina 27710
    Wegener's Granulomatosis
    Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Endometrial Cancer
    Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive Glioma
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Brain and Central Nervous System Tumors
    S9901 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Stage III or Stage IV Hodgkin's Disease
    Duke Comprehensive Cancer Center

    Trial Locations
    Duke Comprehensive Cancer Center
    Veterans Affairs Medical Center - Durham
    Lymphoma
    Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Leukemia
    Chemotherapy in Treating Patients With Sarcoma of the Uterus
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Endometrial Cancer, Sarcoma
    Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Lung Cancer
    Computerized Tomographic Colonography Compared With Standard Diagnostic Procedures in Detecting Colorectal Neoplasia
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Colorectal Cancer
    Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Kidney Cancer
    Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
    Duke Comprehensive Cancer Center

    Trial Locations
    Duke Comprehensive Cancer Center
    Veterans Affairs Medical Center - Durham
    Prostate Cancer
    Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
    Veterans Affairs Medical Center - Durham
    Durham, North Carolina 27705
    Anxiety Disorder, Depression, Fatigue, Lung Cancer
    Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Endometrial Cancer
    Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Brain and Central Nervous System Tumors
    Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Head and Neck Cancer, Kidney Cancer, Neuroblastoma, Ovarian Cancer, Sarcoma, Testicular Germ Cell Tumor
    Temozolomide in Treating Patients With Brain Metastases
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Brain and Central Nervous System Tumors
    Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Brain and Central Nervous System Tumors, Neuroblastoma
    Biological Therapy in Treating Patients With Advanced Cancer
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Breast Cancer, Gastric Cancer, Ovarian Cancer
    Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Previously Untreated Aggressive Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
    Duke Comprehensive Cancer Center

    Trial Locations
    Duke Comprehensive Cancer Center
    Veterans Affairs Medical Center - Durham
    Lymphoma
    Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Leukemia, Lymphoma
    SU5416 Compared to Dexamethasone in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy
    Veterans Affairs Medical Center - Durham
    Durham, North Carolina 27705
    Prostate Cancer
    Combination Chemotherapy Plus Trastuzumab in Treating Patients With Advanced, Recurrent, or Metastatic Colorectal Cancer
    Duke Comprehensive Cancer Center

    Trial Locations
    Duke Comprehensive Cancer Center
    Veterans Affairs Medical Center - Durham
    Colorectal Cancer
    Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
    Duke Comprehensive Cancer Center

    Trial Locations
    Duke Comprehensive Cancer Center
    Veterans Affairs Medical Center - Durham
    Lymphoma
    Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Brain and Central Nervous System Tumors, Lymphoma, Neuroblastoma, Retinoblastoma, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
    Duke Comprehensive Cancer Center

    Trial Locations
    Duke Comprehensive Cancer Center
    Veterans Affairs Medical Center - Durham
    Lymphoma
    Gemcitabine in Treating Patients With Persistent or Recurrent Cancer of the Cervix
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Cervical Cancer
    Busulfan in Treating Children and Adolescents With Refractory CNS Cancer
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Leukemia, Lymphoma, Metastatic Cancer, Retinoblastoma, Sarcoma
    SU5416 in Treating Children With Recurrent or Progressive Brain Tumors
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Brain and Central Nervous System Tumors
    Gemtuzumab Ozogamicin and High-Dose Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
    Duke Comprehensive Cancer Center

    Trial Locations
    Duke Comprehensive Cancer Center
    Veterans Affairs Medical Center - Durham
    Leukemia
    Oltipraz in the Prevention of Lung Cancer in People Who Smoke
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Lung Cancer
    Ecteinascidin 743 in Treating Children With Refractory Solid Tumors
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Unspecified Childhood Solid Tumor, Protocol Specific
    Temozolomide and O6-benzylguanine in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Anaplastic Glioma
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Brain and Central Nervous System Tumors
    Gemcitabine and Cisplatin in Treating Patients With Refractory or Recurrent Cancer of the Cervix
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Cervical Cancer
    Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma
    Duke Comprehensive Cancer Center

    Trial Locations
    Duke Comprehensive Cancer Center
    Veterans Affairs Medical Center - Durham
    Graft Versus Host Disease, Lymphoma